Published in Int J Epidemiol on August 01, 2003
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart (2005) 9.79
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Cardiovascular disease and risk factors in Asia: a selected review. Circulation (2008) 3.00
Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study. J Eval Clin Pract (2011) 2.47
Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One (2013) 1.95
The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med (2008) 1.83
National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr (2011) 1.81
Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ (2006) 1.51
Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health (2006) 1.43
Lipid levels and the risk of ischemic stroke in women. Neurology (2007) 1.23
Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens (2014) 1.04
Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev (2010) 1.04
Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study. Indian Heart J (2014) 1.04
Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan. J Am Heart Assoc (2012) 0.95
The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables. PLoS One (2009) 0.94
Effects of cold air on cardiovascular disease risk factors in rat. Int J Environ Res Public Health (2012) 0.91
Coronary artery calcification by computed tomography in epidemiologic research and cardiovascular disease prevention. J Epidemiol (2012) 0.90
Chinese herbal medicines for hypercholesterolemia. Cochrane Database Syst Rev (2011) 0.89
Evidence-based prescribing of statins: a developing world perspective. PLoS Med (2006) 0.88
Risk of Stroke in Elderly Dialysis Patients. J Korean Med Sci (2017) 0.82
Cardiovascular events in patients with atherothrombotic disease: a population-based longitudinal study in Taiwan. PLoS One (2014) 0.80
Doppler study of cerebral arteries in hypercholesterolemia. Vasc Health Risk Manag (2011) 0.80
A comparison of risk factors for mortality from heart failure in Asian and non-Asian populations: an overview of individual participant data from 32 prospective cohorts from the Asia-Pacific Region. BMC Cardiovasc Disord (2014) 0.80
Identifying Target Risk Factors Using Population Attributable Risks of Ischemic Stroke by Age and Sex. J Stroke (2015) 0.80
Xuesaitong injection as one adjuvant treatment of acute cerebral infarction: a systematic review and meta-analysis. BMC Complement Altern Med (2015) 0.79
Blood pressure, low-density lipoprotein cholesterol, and incidences of coronary artery disease and ischemic stroke in Japanese: the Suita study. Am J Hypertens (2014) 0.79
The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II). Curr Control Trials Cardiovasc Med (2005) 0.78
Stroke Risk Factors, Genetics, and Prevention. Circ Res (2017) 0.78
Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective. Singapore Med J (2016) 0.78
Lipids and Cerebrovascular Disease: Research and Practice. Stroke (2015) 0.78
The impact of body mass index on the associations of lipids with the risk of coronary heart disease in the Asia Pacific region. Prev Med Rep (2015) 0.78
The role of statins in neurosurgery. Neurosurg Rev (2010) 0.78
Subtotal Gastrectomy With Billroth II Anastomosis Is Associated With a Low Risk of Ischemic Stroke in Peptic Ulcer Disease Patients: A Nationwide Population-Based Study. Medicine (Baltimore) (2016) 0.77
Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts. PLoS One (2015) 0.77
What is the association of lipid levels and incident stroke? Int J Cardiol (2016) 0.77
Prevalence of dyslipidemia in patients receiving health checkups: a hospital-based study. Cholesterol (2011) 0.77
Retrospective case review of missed opportunities for primary prevention of stroke and TIA in primary care: protocol paper. BMJ Open (2014) 0.77
Blood pressure, cholesterol and cardiovascular disease in Thailand. Heart Asia (2010) 0.75
Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study. Cardiovasc Diabetol (2015) 0.75
Increased Silent Brain Infarction Accompanied With High Prevalence of Diabetes and Dyslipidemia in Psychiatric Inpatients: A Cross-Sectional Study. Prim Care Companion CNS Disord (2015) 0.75
Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage. J Lipid Res (2011) 0.75
Need for better blood pressure measurement in developing countries to improve prevention of cardiovascular disease. J Epidemiol (2014) 0.75
Comparing Risk Factor Profiles between Intracerebral Hemorrhage and Ischemic Stroke in Chinese and White Populations: Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Impact of Dietary and Metabolic Risk Factors on Cardiovascular and Diabetes Mortality in South Asia: Analysis From the 2010 Global Burden of Disease Study. Am J Public Health (2016) 0.75
New evidence in hypertension and hyperlipidaemia. Heart (2004) 0.75
The Burden of Cardiovascular Disease Attributable to Major Modifiable Risk Factors in Indonesia. J Epidemiol (2016) 0.75
Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association. J Am Heart Assoc (2017) 0.75
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature (2000) 32.30
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell (1998) 18.32
A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature (2001) 11.72
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science (1997) 8.43
Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (1997) 8.24
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ (2000) 7.36
Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia (2012) 7.19
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55
Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell (1996) 6.42
Prevalence of specific language impairment in kindergarten children. J Speech Lang Hear Res (1997) 6.37
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45
Histone-like TAFs within the PCAF histone acetylase complex. Cell (1998) 5.26
Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol (2009) 4.93
Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev (2001) 4.91
Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys (1999) 4.72
Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol (2004) 4.67
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell (2001) 4.58
Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57
Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol (2008) 4.57
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature (1998) 4.47
Activation of PPARgamma coactivator-1 through transcription factor docking. Science (1999) 4.33
Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med (2001) 4.19
Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood (1998) 4.07
The frequency of uterine leiomyomas. Am J Clin Pathol (1990) 4.00
Crystal structure of four-stranded Oxytricha telomeric DNA. Nature (1992) 3.96
Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc Natl Acad Sci U S A (2001) 3.96
Management of raised blood pressure in New Zealand: a discussion document. BMJ (1993) 3.96
Aromatic hydrogen bond in sequence-specific protein DNA recognition. Nat Struct Biol (1996) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens (2003) 3.67
Effectiveness of community health workers in the care of persons with diabetes. Diabet Med (2006) 3.66
PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet (1997) 3.58
ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol (2001) 3.55
A presynaptic inositol-5-phosphatase. Nature (1996) 3.54
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest (1998) 3.51
Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell (1999) 3.47
Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell (2000) 3.44
Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. J Neurosci (2000) 3.44
Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis (2008) 3.42
State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993. Public Health Rep (1998) 3.41
Three-dimensional structure of an evolutionarily conserved N-terminal domain of syntaxin 1A. Cell (1998) 3.40
Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature (1998) 3.36
Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. Neuron (1999) 3.33
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet (2001) 3.32
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene (1999) 3.23
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther (2012) 3.22
Randomized clinical trial of early laparoscopy in the management of acute non-specific abdominal pain. Br J Surg (1999) 3.18
A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol (1997) 3.10
Real time detection of DNA.RNA hybridization in living cells. Proc Natl Acad Sci U S A (1998) 3.10
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull (1994) 3.09
Randomised studies of income supplementation: a lost opportunity to assess health outcomes. J Epidemiol Community Health (1999) 3.05
Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet (1995) 3.05
Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tob Control (2009) 3.05
Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell (2000) 3.00
Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology (1993) 3.00
Histone chaperone Asf1 is required for histone H3 lysine 56 acetylation, a modification associated with S phase in mitosis and meiosis. Proc Natl Acad Sci U S A (2006) 2.98
Human magnetic resonance imaging at 8 T. NMR Biomed (1998) 2.96
ORegAnno: an open access database and curation system for literature-derived promoters, transcription factor binding sites and regulatory variation. Bioinformatics (2006) 2.93
Identification of a translation initiation factor 3 (eIF3) core complex, conserved in yeast and mammals, that interacts with eIF5. Mol Cell Biol (1998) 2.91
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ (1996) 2.90
Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci (2001) 2.84
Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet (1988) 2.84
Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet (2000) 2.82
Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes. Mol Biol Cell (1999) 2.80
Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care (2004) 2.77
cisRED: a database system for genome-scale computational discovery of regulatory elements. Nucleic Acids Res (2006) 2.75
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. Mol Cell (1999) 2.71
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature (1996) 2.71
New variants of a method of MRI scale standardization. IEEE Trans Med Imaging (2000) 2.69
Lyme arthritis in the Hunter Valley. Med J Aust (1982) 2.68